News

CIDRAP14d
FDA approves Merck RSV monoclonal antibody shot for infants
Merck announced yesterday that the US Food and Drug Administration (FDA) has approved its monoclonal antibody vaccine clesrovimab-cfor (Enflonsia) for preventing respiratory syncytial virus (RSV) in ...
Healio14d
FDA approves clesrovimab for preventing RSV in infants
The FDA approved the monoclonal antibody clesrovimab-cfor for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns, Merck announced.Merck said it plans to make the ...
PharmExec11d
FDA Approves Expanded Indication for Moderna’s Respiratory Syncytial Virus Vaccine mRESVIA
RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...
FDA approves new RSV treatment for infants
CHARLOTTE — The Food and Drug Administration approved a new vaccine to help protect infants from RSV on Monday. The treatment ...
NBC New York15d
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC New York
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca By Annika Kim Constantino, CNBC • Published June 9, 2025 • Updated on June 9, 2025 at 4:15 pm ...
The Gazette16d
US FDA approves Merck's RSV antibody for infants | U.S. & World | gazette.com - Colorado Springs Gazette
US FDA approves Merck's RSV antibody for infants. ... The CDC currently recommends two immunization options for babies to be protected from severe RSV — an RSV vaccine given to the mother during ...
Reuters16d
US FDA approves Merck's RSV antibody for infants | Reuters
US FDA approves Merck's RSV antibody for infants. ... The CDC currently recommends two immunization options for babies to be protected from severe RSV — an RSV vaccine given to the mother during ...
NBC Bay Area15d
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC Bay Area
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus. Skip to content. Main Navigation. Search. Search for: Local Weather ...
NBC Chicago15d
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC Chicago
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca By Annika Kim Constantino, CNBC • Published June 9, 2025 • Updated on June 9, 2025 at 3:15 pm ...
NBC Washington15d
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC4 Washington
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca By Annika Kim Constantino, CNBC • Published June 9, 2025 • Updated on June 9, 2025 at 4:15 pm ...
NBC DFW15d
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC 5 Dallas-Fort Worth
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca By Annika Kim Constantino, CNBC • Published June 9, 2025 • Updated on June 9, 2025 at 3:15 pm ...
NBC Los Angeles15d
FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - NBC Los Angeles
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus. Skip to content. Main Navigation. Search. Search for: Local NBC4 Investigates ...